SCHEMBL6834584

SCHEMBL6834584

CCCCCCCCC1OC1CCCCCCCC(=O)OCC

nearest known ligand 0.55

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
DGKA P23743 1/20 0.55
PAM P19021 2/20 0.50
ALDH1A1 P00352 2/20 0.49
USP2 O75604 1/20 0.49
ALOX15 P16050 1/20 0.49
TDP1 Q9NUW8 1/20 0.49
TSHR P16473 1/20 0.47
MAPT P10636 1/20 0.47
LMNA P02545 2/20 0.46
DNM1 Q05193 1/20 0.46
CYP1A2 P05177 1/20 0.46
KDM4E B2RXH2 1/20 0.45
DUSP3 P51452 1/20 0.45
MEN1 O00255 1/20 0.45
KMT2A Q03164 1/20 0.45
PRKCA P17252 2/20 0.44
PRKCE Q02156 2/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19427008 1.00 DGKA (0.55) DGKAPAMALDH1A1USP2ALOX15
SCHEMBL12843051 1.00 DGKA (0.55) DGKAPAMALDH1A1USP2ALOX15
SCHEMBL17562208 0.95 DGKA (0.50) DGKAPAMALDH1A1USP2ALOX15
SCHEMBL9386975 0.95 ALDH1A1 (0.53) DGKAPAMALDH1A1USP2ALOX15
SCHEMBL16663693 0.92 DGKA (0.56) DGKAPAMALDH1A1TSHRMAPT
SCHEMBL9186721 0.90 DGKA (0.70) DGKAPAMALDH1A1TSHRMAPT
SCHEMBL7938480 0.89 DGKA (0.62) DGKAPAMALDH1A1TSHRMAPT
SCHEMBL11909432 0.89 DGKA (0.62) DGKAPAMALDH1A1TSHRMAPT
SCHEMBL1471700 0.89 DGKA (0.53) DGKAPAMALDH1A1TSHRMAPT
SCHEMBL7941998 0.89 DGKA (0.62) DGKAPAMALDH1A1TSHRMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 28 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4725976-A1 POLYMERIC CYCLOALIPHATIC EPOXIDES ARKEMA FRANCE (FR) 2026-04-15 EP disclosed
EP-4563614-A1 CURABLE COMPOSITION COMPRISING A MULTIFUNCTIONAL HALOGENATED THIOXANTHONE AND ITS USES ARKEMA FRANCE (FR) 2025-06-04 EP disclosed
EP-4451879-A1 METHODS FOR ISOLATING ANTIMICROBIAL MICROORGANISMS FROM AGRICULTURAL PRODUCTS AND USES THEREOF Apeel Technology, Inc. (US) 2024-10-30 EP disclosed
US-20230380435-A1 METHOD FOR PREPARING AND PRESERVING SANITIZED PRODUCTS APEEL TECHNOLOGY, INC. 2023-11-30 US disclosed
US-11723377-B2 Method for preparing and preserving sanitized products APEEL TECHNOLOGY, INC. (US) 2023-08-15 US disclosed
US-20230232872-A1 COMPOUNDS AND FORMULATIONS FOR PROTECTIVE COATINGS APEEL TECHNOLOGY, INC. 2023-07-27 US disclosed
WO-2023122793-A1 METHODS FOR ISOLATING ANTIMICROBIAL MICROORGANISMS FROM AGRICULTURAL PRODUCTS AND USES THEREOF APEEL TECHNOLOGY, INC. (US) 2023-06-29 WO disclosed
US-20230200405-A1 METHODS FOR ISOLATING ANTIMICROBIAL MICROORGANISMS FROM AGRICULTURAL PRODUCTS AND USES THEREOF APEEL TECHNOLOGY, INC. 2023-06-29 US disclosed
US-11641865-B2 Compounds and formulations for protective coatings APEEL TECHNOLOGY, INC. (US) 2023-05-09 US disclosed
US-20210115679-A1 VINYL COMPOSITION TILE AND METHOD FOR PRODUCING SAME TAJIMA ROOFING INC. (JP) 2021-04-22 US disclosed
WO-2011029738-A1 COMPOSITION COMPRISING A POLYMER BASED ON PARTICULAR POLYOLS, AND COSMETIC TREATMENT PROCESS L'ORÉAL (FR) 2011-03-17 WO disclosed
WO-2009138508-A1 METHOD FOR PREPARING POLYMER BIOPLASTICIZERS TISSAGE ET ENDUCTION SERGE FERRARI SA (FR) 2009-11-19 WO disclosed
US-6750182-B1 ADDING TO THE OIL FROM ABOUT 1 TO ABOUT 25 WT % OF A POLYALPHA OLEFIN OIL WHEREBY THE SLUDGE RESISTANCE OF THE COMPOSITION IS ENHANCED EXXONMOBIL RESEARCH AND ENGINEERING COMPANY 2004-06-15 US disclosed
EP-1121405-B1 METHOD FOR PRODUCING LUBRICATING OILS WITH ANTI RUST PROPERTIES EXXONMOBIL RES & ENG CO (US) 2003-05-07 EP disclosed
EP-1123366-B1 POLAR OIL BASED INDUSTRIAL OILS WITH ENHANCED SLUDGE PERFORMANCE EXXONMOBIL RES & ENG CO (US) 2002-12-18 EP disclosed
EP-1123366-A1 POLAR OIL BASED INDUSTRIAL OILS WITH ENHANCED SLUDGE PERFORMANCE ExxonMobil Research and Engineering Company (US) 2001-08-16 EP disclosed
EP-1121405-A1 METHOD FOR PRODUCING LUBRICATING OILS WITH ANTI RUST PROPERTIES ExxonMobil Research and Engineering Company (US) 2001-08-08 EP disclosed
US-6235687-B1 MIXTURES EXXON RESEARCH AND ENGINEERING COMPANY 2001-05-22 US disclosed
WO-2000022071-A1 POLAR OIL BASED INDUSTRIAL OILS WITH ENHANCED SLUDGE PERFORMANCE EXXON RESEARCH AND ENGINEERING COMPANY (US) 2000-04-20 WO disclosed
WO-2000022074-A1 METHOD FOR PRODUCING LUBRICATING OILS WITH ANTI-RUST PROPERTIES EXXON RESEARCH AND ENGINEERING COMPANY (US) 2000-04-20 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230380435-A1 METHOD FOR PREPARING AND PRESERVING SANITIZED PRODUCTS TET2, SI, CAT DGKA 1845/4885PAM 993/4885ALDH1A1 1243/4885
US-11723377-B2 Method for preparing and preserving sanitized products TET2, SI, CAT DGKA 1845/4885PAM 993/4885ALDH1A1 1243/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.